健康行为改变整合理论联合助推策略在高尿酸血症患者健康管理中的应用

史丽妙; 赵奇江; 徐瑾; 张满燕

doi:10.16766/j.cnki.issn.1674-4152.003591

健康行为改变整合理论联合助推策略在高尿酸血症患者健康管理中的应用

doi: 10.16766/j.cnki.issn.1674-4152.003591

1.
绍兴文理学院附属医院校保健办，浙江绍兴 312000
2.
绍兴文理学院附属医院体检中心
3.
绍兴市中医院体检中心，浙江绍兴 312000
4.
绍兴文理学院附属医院儿童康复科

基金项目:

浙江省医药卫生科技计划项目 2020ZH059

详细信息

通讯作者:
张满燕，E-mail：zjsxmy85854357@163.com

中图分类号: R589.7
计量
- 文章访问数: 198
- HTML全文浏览量: 54
- PDF下载量: 12
- 被引次数: 0
出版历程
- 收稿日期: 2024-04-19
- 网络出版日期: 2024-09-05

Application of integrated theory of health behavior change combined with promotion strategy in the health management of patients with hyperuricemia

1.
School Health Office of Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang 312000, China

摘要

摘要: 目的分析健康行为改变整合理论联合助推策略对高尿酸血症患者血尿酸、糖脂代谢水平、自我管理能力及生活方式的影响，为高尿酸血症患者健康管理提供理论依据。方法选取2021年5月—2023年4月在绍兴文理学院附属医院健康体检发现的156例高尿酸血症患者，根据随机数字表法将其分为对照组(78例)和观察组(78例)。对照组患者应用常规健康管理，观察组在对照组基础上应用健康行为改变整合理论联合助推策略干预方法。比较2组患者干预前后血尿酸水平、糖脂代谢指标、慢性病自我管理问卷(CDSMQ)及健康促进生活方式量表(HPLP-ⅡR)得分差异。结果干预后，观察组患者血尿酸(UA)、低密度脂蛋白(LDL)及空腹血糖(FBG)均低于对照组，且高密度脂蛋白(HDL)高于对照组，差异均有统计学意义(P＜0.05)；观察组患者CDSMQ量表及HPLP-ⅡR量表总分分别为(28.15±2.33)分、(133.41±10.85)分，均高于对照组[(22.51±3.79)分、(99.67±8.58)分，P＜0.05]。结论健康行为改变整合理论联合助推策略能有效改善高尿酸血症患者尿酸、血脂、血糖水平，提高患者自我管理能力，改善其生活方式，值得临床应用。
- 高尿酸血症 /
- 健康行为改变整合理论 /
- 助推策略 /
- 健康管理 /
- 生活方式
Abstract: Objective To analyze the impact of the integration theory of health behavior change and the combined promotion strategy on the blood uric acid, glucose and lipid metabolism levels, self-management ability, and lifestyle of patients with hyperuricemia, providing a theoretical basis for the health management of patients with hyperuricemia. Methods A total of 156 patients with hyperuricemia conducting health examinations the Affiliated Hospital of Shaoxing University of Arts and Sciences from May 2021 to April 2023 were selected. They were randomly divided into a control group and an observation group, with 78 cases in each group, using a random number table method. The control group received routine health management, while the observation group received integrated theory of health behavior change combined with supportive nursing interventions on the basis of the control group. The changes in blood uric acid (UA) levels, glucose and lipid metabolism indicators, as well as the differences in scores on the chronic disease self-management questionnaire (CDSMQ) and the health promotion lifestyle profile Ⅱ (HPLP-ⅡR) between two groups of patients before and after intervention were compared. Results After intervention, the levels of UA, low-density lipoprotein (LDL) and fasting blood glucose (FBG) in the observation group were lower than those in the control group, and the high-density lipoprotein (HDL) index was higher than the control group (P < 0.05). The total scores of the CDSMQ scale and HPLP-ⅡR scale in the observation group were (28.15±2.33) points and (133.41±10.85) points, respectively, which were higher than those in the control team [(22.51±3.79) points and (99.67±8.58) points, P < 0.05]. Conclusion The combination of integrated theory of health behavior change and promotion strategy can effectively improve the levels of uric acid, blood lipids, and blood glucose in patients with hyperuricemia, enhance their self-management ability, and improve their lifestyle, which is worthy of clinical application.
- Hyperuricemia /
- Integrated theory of health behavior change /
- Boosting strategy /
- Health management /
- Life style

HTML全文

表 1 2组高尿酸血症患者一般资料比较

Table 1. Comparison of general data between two groups of hyperuricemia patients

项目	对照组(n=78)	观察组(n=78)	统计量	P值
性别(例)			0.103^a	0.748
男性	41	43
女性	37	35
年龄(x ±s，岁)	52.16±10.35	51.76±8.42	0.265^b	0.792
文化程度(例)			0.257^a	0.612
中专至大专	25	28
本科及以上	53	50
婚姻状况(例)			0.381^a	0.537
离婚/丧偶/未婚	13	16
已婚	65	62
并存疾病(例)			0.548^a	0.908
肥胖	18	17
高脂血症	34	31
糖尿病	6	8
无	20	22
病程(x ±s，年)	3.11±0.72	3.03±0.95	0.593^b	0.554
注：^a为χ²值，^b为t值。

下载: 导出CSV

表 2 2组高尿酸血症患者干预前后血尿酸及糖脂代谢水平比较(x ±s)

Table 2. Comparison of serum uric acid, glucose metabolism, and lipid metabolism levels between two groups of hyperuricemia patients before and after intervention (x ±s)

组别	例数	UA(μmol/L)		LDL(mmol/L)		HDL(mmol/L)		FBG(mmol/L)
组别	例数	干预前	干预后	干预前	干预后	干预前	干预后	干预前	干预后
对照组	78	479.52±68.70	447.88±50.46	3.14±0.75	3.04±0.84	1.17±0.20	1.20±0.26	7.02±1.11	6.65±0.73
观察组	78	485.73±53.29	402.29±41.17	3.20±0.83	2.81±0.43	1.15±0.24	1.35±0.18	6.93±1.03	6.21±0.66
统计量		0.631^a	4.287^b	0.474^a	2.286^b	0.565^a	5.136^b	0.525^a	4.401^b
P值		0.529	＜0.001	0.636	0.029	0.573	＜0.001	0.600	＜0.001
注：^a为t值，^b为F值。

下载: 导出CSV

表 3 2组高尿酸血症患者干预前后自我管理能力及健康促进行为水平比较(x ±s，分)

Table 3. Comparison of self-management ability and health-promoting behavior level between two groups of hyperuricemia patients before and after intervention (x ±s, points)

组别	例数	CDSMQ量表		HPLP-ⅡR量表
组别	例数	干预前	干预后	干预前	干预后
对照组	78	15.42±4.10	22.51±3.79	77.54±4.86	99.67±8.58
观察组	78	14.81±3.62	28.15±2.33	78.81±5.20	133.41±10.85
统计量		0.985^a	10.562^b	1.576^a	18.733^b
P值		0.326	＜0.001	0.117	＜0.001
注：^a为t值，^b为F值。

下载: 导出CSV

参考文献(21)

[1]	陈浩, 吴谦, 章如山, 等. 江西婺源高血压患者体重指数和腰高比与高尿酸血症的关联性研究[J]. 中华全科医学, 2023, 21(8): 1284-1286, 1378. doi: 10.16766/j.cnki.issn.1674-4152.003103 CHEN H, WU Q, ZHANG R S, et al. The relationship between body mass index and waist-height ratio and hyperuricemia in patients with hypertension in Wuyuan, Jiangxi Province[J]. Chinese Journal of General Practice, 2023, 21(8): 1284-1286, 1378. doi: 10.16766/j.cnki.issn.1674-4152.003103
[2]	李晓琴, 高凌, 陈勇, 等. 高尿酸血症患者的危险因素分析[J]. 临床内科杂志, 2021, 38(10): 695-696. doi: 10.3969/j.issn.1001-9057.2021.10.014 LI X Q, GAO L, CHEN Y, et al. Patients with high uric acid hematic disease risk factor analysis[J]. Journal of Clinical Internal Medicine, 2021, 38(10): 695-696. doi: 10.3969/j.issn.1001-9057.2021.10.014
[3]	章人尹, 杨冬冬, 徐丽丽. 基于健康教育模式对高尿酸血症患者的干预效果研究[J]. 中国基层医药, 2022, 29(4): 611-614. doi: 10.3760/cma.j.issn1008-6706.2022.04.030 ZHANG R Y, YANG D D, XU L L. Efficacy of intervention based on a health education model in patients with hyperuricemia[J]. Chinese Journal of Primary Medicine and Pharmacy, 2022, 29(4): 611-614. doi: 10.3760/cma.j.issn1008-6706.2022.04.030
[4]	谢贵华, 成忠莎, 万艳平, 等. 基于健康行为改变整合理论的健康教育在心脏机械瓣膜置换术后患者延续护理中的应用[J]. 护士进修杂志, 2023, 38(1): 73-76. https://www.cnki.com.cn/Article/CJFDTOTAL-FSJX202301016.htm XIE G H, CHENG Z S, WAN Y P, et al. Application of health education based on the integrated theory of health behavior change in continuous nursing of patients after mechanical heart valve replacement[J]. Journal of Nurses Training, 2023, 38(1): 73-76. https://www.cnki.com.cn/Article/CJFDTOTAL-FSJX202301016.htm
[5]	RAUPRICH O, MÖLLENKAMP M, REIMANN J, et al. Effectiveness and ethical evaluation of nudging to promote the self-management in diabetes mellitus type 2[J]. Gesundheitswesen, 2022, 84(11): 1059-1066. doi: 10.1055/a-1709-0591
[6]	KWAN Y H, CHENG T Y, YOON S, et al. A systematic review of nudge theories and strategies used to influence adult health behaviour and outcome in diabetes management[J]. Diabetes Metab, 2020, 46(6): 450-460. doi: 10.1016/j.diabet.2020.04.002
[7]	DING Y Y, JIANG H, LIU J Z, et al. Effects of the theory of planned behavior and nudge strategy-based intervention on the adherence to anticoagulation treatment in patients with non-valvular atrial fibrillation[J]. Geriatr Nurs, 2023, 51: 17-24. doi: 10.1016/j.gerinurse.2023.01.023
[8]	中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志, 2020, 36(1): 1-2, 13. doi: 10.3760/cma.j.issn.1000-6699.2020.01.001 Chinese Society of Endocrinology, Chinese Medical Association. Guideline for the diagnosis and management of hyperuricemia and gout in China(2019)[J]. Chinese Journal of Endocrinology and Metabolism, 2020, 36(1): 1-2, 13. doi: 10.3760/cma.j.issn.1000-6699.2020.01.001
[9]	The national council on ageing, Challenges and success in implementing Chronic Disease Self-Management Program(CDSMQ)-final report[R]. NCOA, 2004: 35-40.
[10]	曹文君, 郭颖, 平卫伟, 等. HPLP-Ⅱ健康促进生活方式量表中文版的研制及其性能测试[J]. 中华疾病控制杂志, 2016, 20(3): 286-289. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ201603018.htm CAO W J, GUO Y, PING W W, et al. Development and psychometric tests of a Chinese version of the HPLP-Ⅱ Scales[J]. Chinese Journal of Disease Control & Prevention, 2016, 20(3): 286-289. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ201603018.htm
[11]	YANAI H, ADACHI H, HAKOSHIMA M, et al. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease[J]. Int J Mol Sci, 2021, 22(17): 9221. DOI: 10.3390/ijms22179221.
[12]	孔茹, 郑杰. 健康行为改变整合理论下的盆底肌康复护理在宫颈癌术后尿潴留患者中的应用观察[J]. 检验医学与临床, 2022, 19(5): 688-691. doi: 10.3969/j.issn.1672-9455.2022.05.031 KONG R, ZHENG J. Health behavior change under the theory of integration of pelvic floor muscle rehabilitation nursing in the application of cervical cancer patients with postoperative urinary retention[J]. Laboratory Medicine and Clinic, 2022, 19(5): 688-691. doi: 10.3969/j.issn.1672-9455.2022.05.031
[13]	肖湘成. 对高尿酸血症危害的认识与患者健康管理的思考[J]. 中华健康管理学杂志, 2023, 17(4): 241-244. doi: 10.3760/cma.j.cn115624-20230110-00020 XIAO X C. Awareness of the harm of hyperuricaemia and thoughts on patient health management[J]. Chinese Journal of Health Management, 2023, 17(4): 241-244. doi: 10.3760/cma.j.cn115624-20230110-00020
[14]	张建平. 多学科健康教育团队对高尿酸血症患者疾病防治知识及生活方式干预效果评价: 评《高尿酸血症》[J]. 中国医学装备, 2021, 18(2): 182-183. doi: 10.3969/j.issn.1672-8270.2021.02.045 ZHANG J P. Evaluation of disease prevention knowledge and lifestyle intervention Effect of Multi-disciplinary health education Team in patients with hyperuricemia: a review of Hyperuricemia[J]. China Medical Equipment, 2021, 18(2): 182-183. doi: 10.3969/j.issn.1672-8270.2021.02.045
[15]	毛莉华, 余婷婷, 吴菊蕾, 等. 思维导图结合回授法用于高尿酸血症患者饮食健康教育[J]. 护理学杂志, 2022, 37(24): 5-9. doi: 10.3870/j.issn.1001-4152.2022.24.005 MAO L H, YU T T, WU J L, et al. Application of mind mapping combined with teach-back in diet management for patients with hyperuricemia[J]. Journal of Nursing Science, 2022, 37(24): 5-9. doi: 10.3870/j.issn.1001-4152.2022.24.005
[16]	陈赟, 李国敏, 杨珺雯, 等. 高尿酸血症患者基于辨体施护联合保护动机理论健康管理的效果观察[J]. 护理学报, 2023, 30(16): 73-78. https://www.cnki.com.cn/Article/CJFDTOTAL-NFHL202316015.htm CHEN Y, LI G M, YANG J W, et al. Effect of dialectical nursing combined with protection motivation theory in health management for patients with hyperuricemia[J]. Journal of Nursing(China), 2023, 30(16): 73-78. https://www.cnki.com.cn/Article/CJFDTOTAL-NFHL202316015.htm
[17]	KHA-MOUA K, PAULUS A B. Patient peer-to-peer mentoring for patients with kidney failure: methods, facilitators, and lessons learned[J]. Nephrol Nurs J, 2021, 48(3): 227-235. doi: 10.37526/1526-744X.2021.48.3.227
[18]	包维为, 王欢, 邵珠林, 等. 健康体检人群高尿酸血症发生情况及与腰臀比、糖脂代谢的关系[J]. 河北医药, 2022, 44(20): 3173-3175, 3179. doi: 10.3969/j.issn.1002-7386.2022.20.033 BAO W W, WANG H, SHAO Z L, et al. Investigation and study: hyperuricemia among healthy examinees and how to impact on waist-hip ratio and glycolipid metabolism from 2020 to 2021[J]. Hebei Medical Journal, 2022, 44(20): 3173-3175, 3179. doi: 10.3969/j.issn.1002-7386.2022.20.033
[19]	仝小玲, 张连文, 宗成, 等. 体检人群高尿酸血症与体重指数的相关性研究[J]. 中国临床医生杂志, 2022, 50(10): 1158-1162. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYS202210008.htm TONG X L, ZHANG L W, ZONG C, et al. Correlation between hyperuricemia and body mass index in a physical examination population[J]. Chinese Journal For Clinicians, 2022, 50(10): 1158-1162. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYS202210008.htm
[20]	耿文垚, 孙晓方, 李丽, 等. 健康行为过程取向理论及助推策略相结合的妊娠糖尿病患者饮食管理方案的构建[J]. 中国护理管理, 2022, 22(8): 1199-1204. doi: 10.3969/j.issn.1672-1756.2022.08.017 GENG W Y, SUN X F, LI L, et al. Development of a diet management program for patients with gestational diabetes based on a combination of Health Action Process Approach and nudges strategies[J]. Chinese Nursing Management, 2022, 22(8): 1199-1204. doi: 10.3969/j.issn.1672-1756.2022.08.017
[21]	王晓萱, 张振香, 林蓓蕾, 等. 助推理论在慢性病自我管理中的应用研究热点及前沿分析[J]. 中国慢性病预防与控制, 2023, 31(6): 462-466. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXB202306013.htm WANG X X, ZHANG Z X, LIN B L, et al. Booster theory application in the chronic disease self-management hotspot and frontier analysis[J]. Chinese Journal of Prevention and Control of Chronic Diseases, 2023, 31(6): 462-466. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXB202306013.htm